PGC-1β, PGC-1 homologue and uses therefor
The invention provides isolated nucleic acid molecules, designated PGC-1β nucleic acid molecules, which encode novel PGC-1 related coactivator molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PGC-1β nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PGC-1β gene has been introduced or disrupted. The invention still further provides isolated PGC-1β proteins, fusion proteins, antigenic peptides and anti-PGC-1β antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
1. A method for identifying a compound which binds to a polypeptide which is encoded by a nucleic acid molecule comprising a nucleotide sequence which is at least 97% identical to a nucleic acid comprising the nucleotide sequence of SEQ ID NO: 4 or 6, wherein said polypeptide modulates one or more of the following biological activities: activity of a nuclear receptor and/or nuclear respiratory factor 1 (NRF1); brown adipose cell determination and/or differentiation; mitochondrial activity and/or biogenesis; or fatty acid β-oxidation and wherein said method comprises:
i) contacting the polypeptide, or a cell expressing the polypeptide with a test compound; and
ii) determining whether the polypeptide binds to the test compound.
2. The method of claim 1 , wherein the polypeptide is encoded by a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 4 or 6.
3. The method of claim 1 , wherein the polypeptide further comprises a heterologous amino acid sequence.
4. The method of claim 2 , wherein the polypeptide further comprises a heterologous amino acid sequence.
5. A method for identifying a compound which binds to a polypeptide comprising an amino acid sequence which is at least 97% identical to the amino acid sequence of SEQ ID NO: 2 or 5, wherein said polypeptide modulates one or more of the following biological activities: activity of a nuclear receptor and/or nuclear respiratory factor 1 (NRF1); brown adipose cell determination and/or differentiation; mitochondrial activity and/or biogenesis; or fatty acid β-oxidation and wherein said method comprises:
i) contacting the polypeptide, or a cell expressing the polypeptide with a test compound; and
ii) determining whether the polypeptide binds to the test compound.
6. The method of claim 5 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 4 or 6.
7. The method of claim 5 , wherein the polypeptide further comprises a heterologous amino acid sequence.
8. The method of claim 6 , wherein the polypeptide further comprises a heterologous amino acid sequence.
9. The method of any one of claims 1 - 8 , wherein the binding of the test compound to the polypeptide is detected by a method selected from the group consisting of:
a) detection of binding by direct detection of test compound/polypeptide binding;
b) detection of binding using a competition binding assay; and
c) detection of binding using an assay for PGC-1β activity.